ICE Midday: Canola Rising Again
WINNIPEG, Manitoba--The ICE Futures canola market continued to expand its gains Tuesday with help from most comparable oils.
Chicago soyoil and European rapeseed were both on the rise, while crude oil also was higher as traders await the U.S. Federal Reserve's key interest rate decision Wednesday. However, Malaysian palm oil was lower after India implemented a new 20% import tax on edible oils.
One analyst had heard that a grain company was particularly aggressive in buying canola recently and added if the canola market's current momentum could bring the November price up to C$600 per tonne sooner than later.
The Canadian dollar was steady compared with Monday's close. Statistics Canada reported Tuesday the country's annual inflation rate dropped to 2% in August, the Bank of Canada's target rate.
About 19,700 contracts have traded at 11:18 a.m. ET. Prices in Canadian dollars per metric tonne:
Canola Price Change Nov 573.50 up 8.80 Jan 586.40 up 8.10 Mar 597.80 up 7.10 May 605.70 up 5.90
Source: Commodity News Service Canada, news@marketsfarm.com
(END) Dow Jones Newswires
September 17, 2024 11:52 ET (15:52 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks